Based on the ANNOVIS BIO INC. DL-0001 stock forecast from 0 analysts, the average analyst target price for ANNOVIS BIO INC. DL-0001 is not available over the next 12 months. ANNOVIS BIO INC. DL-0001’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ANNOVIS BIO INC. DL-0001 is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, ANNOVIS BIO INC. DL-0001’s stock price was EUR 10.64. ANNOVIS BIO INC. DL-0001’s stock price has changed by +3.50% over the past week, -1.12% over the past month and -19.52% over the last year.
No recent analyst target price found for ANNOVIS BIO INC. DL-0001
No recent average analyst rating found for ANNOVIS BIO INC. DL-0001
Company Overview ANNOVIS BIO INC. DL-0001
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which is in Phase 3 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania. Address: 1055 Westlakes Drive, Berwyn, PA, United States, 19312 Read Less
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which is in Phase 3 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neur...Read More
N/A
N/A
6
December
EUR
Germany
Adjusted Closing Price for ANNOVIS BIO INC. DL-0001 (07X:F)
Loading...
Unadjusted Closing Price for ANNOVIS BIO INC. DL-0001 (07X:F)
Loading...
Share Trading Volume for ANNOVIS BIO INC. DL-0001 Shares
Loading...
Compare Performance of ANNOVIS BIO INC. DL-0001 Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for 07X:F
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To ANNOVIS BIO INC. DL-0001 (Sector: Biotechnology )
Frequently Asked Questions About ANNOVIS BIO INC. DL-0001 (07X:F) Stock
Stock Target Advisor's fundamental analysis for ANNOVIS BIO INC. DL-0001's stock is Bearish.
Unfortunately we do not have enough data on 07X:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 07X:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 07X:F's stock to indicate if its overvalued.
The last closing price of 07X:F's stock was EUR 10.64.
The most recent market capitalization for 07X:F is EUR 0.14B.
Unfortunately we do not have enough analyst data on 07X:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains ANNOVIS BIO INC. DL-0001's stock.
As per our most recent records ANNOVIS BIO INC. DL-0001 has 6 Employees.
Sorry we do not have any infomation available on ANNOVIS BIO INC. DL-0001's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 07X:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
